subscribeSubscribe
price-trendAsk Us
BeiGene & SpringWorks Present Clinical Data Lifirafenib, in ComBO Mirdametinib

BeiGene & SpringWorks Present Clinical Data Lifirafenib, in ComBO Mirdametinib
BUSINESSWIRE
17 Apr 2023
Share Share
SpringWorks & BeiGene Present Clinical Data on Lifirafenib, combo Mirdametinib

SpringWorks & BeiGene Present Clinical Data on Lifirafenib, combo Mirdametinib
GLOBENEWSWIRE
17 Apr 2023
Share Share
SpringWorks Announces of Phase 1b Clinical Trial of MEK Inhibitor PD-0325901

SpringWorks Announces of Phase 1b Clinical Trial of MEK Inhibitor PD-0325901
BUSINESSWIRE
06 May 2019
Share Share
SpringWorks names a CEO, inks a combo therapy deal with BeiGene

SpringWorks names a CEO, inks a combo therapy deal with BeiGene
Amirah Al Idrus FIERCE BIOTECH
06 Sep 2018
Share Share